Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Slideshows|July 18, 2019
Treatment Intensification in Type 2 Diabetes: 3 Cases
Author(s)Sudipa Sarkar, MD
When intensifying T2DM therapy to reach glycemic goals, newer agents target common comorbidities. Which would you choose in these 3 scenarios?
Advertisement
Choice of antihyperglycemic agent after metformin can now be selected to also address comorbidites often seen in T2DM patients. Each of the 3 patients in this short case quiz presents a challenge as well as an opportonity to optimize diabetes care. Â
Advertisement
Related to this article
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Advertisement
Advertisement
Trending on Patient Care Online
1
Abbott's Amulet 360 Linked to Low Stroke Risk at 1 Year in Late-Breaking Research
2
When Night Sweats Signal Something Other Than Menopause
3
4 FDA Decisions for Primary Care to Know from October 2026
4
New Schizophrenia Treatment Addresses Long-Standing LAI Barriers
5